A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.

Alendronate was associated with a high number of CDI ADRs relative to other drugs in FAERS. This signal was strongest for women and those 40 years or older. This interesting finding should be interpreted with caution, and further research is warranted.